The chemical class of IgG2a inhibitors is characterized by a diverse array of compounds which can indirectly influence the production or activity of IgG2a antibodies. These inhibitors function by modulating various aspects of the immune response, particularly T-cell and B-cell activities, which are crucial for antibody production. Cyclosporin A, Hydrocortisone, Methotrexate, and Azathioprine are classical examples of immunosuppressants that can impact IgG2a levels by suppressing the overall immune response. Cyclosporin A, for instance, is known for its ability to inhibit T-cell activation, which is a key step in the immune response leading to antibody production. Hydrocortisone and other corticosteroids like Prednisone work by reducing inflammation and immune system activity, thereby potentially decreasing IgG2a production. Mycophenolate Mofetil and Sirolimus (Rapamycin) are also notable for their roles in suppressing immune cell proliferation, which could lead to reduced IgG2a levels. Tacrolimus, similar to Cyclosporin A, inhibits T-cell activation, impacting the immune response and, consequently, IgG2a production.
Chloroquine, while primarily an antimalarial, has immunomodulatory effects that could influence IgG2a levels. Fingolimod, a modulator of sphingosine 1-phosphate receptors, affects the egress of lymphocytes from lymph nodes, potentially leading to reduced IgG2a production. Tofacitinib, a Janus kinase (JAK) inhibitor, and Leflunomide, which inhibits pyrimidine synthesis, are examples of compounds that modulate immune signaling pathways, potentially impacting the production of IgG2a antibodies. In summary, IgG2a inhibitors encompass a range of compounds primarily used for immunosuppression. These chemicals do not directly interact with IgG2a antibodies but affect their production and activity by modulating the immune system. This class of inhibitors highlights the intricate relationship between the immune system and antibody production, offering insights into how modulation of immune responses can influence specific antibody classes like IgG2a.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $62.00 $90.00 $299.00 $475.00 $1015.00 $2099.00 | 69 | |
Inhibits T-cell activation, potentially reducing IgG2a production. | ||||||
Hydrocortisone | 50-23-7 | sc-300810 | 5 g | $100.00 | 6 | |
A corticosteroid that suppresses immune response, possibly lowering IgG2a levels. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $92.00 $209.00 | 33 | |
Antimetabolite and immune system suppressant, may decrease IgG2a production. | ||||||
Azathioprine | 446-86-6 | sc-210853D sc-210853 sc-210853A sc-210853B sc-210853C | 500 mg 1 g 2 g 5 g 10 g | $199.00 $173.00 $342.00 $495.00 $690.00 | 1 | |
Immunosuppressive compound, potentially reducing IgG2a levels. | ||||||
Mycophenolate mofetil | 128794-94-5 | sc-200971 sc-200971A | 20 mg 100 mg | $36.00 $107.00 | 1 | |
Suppresses T- and B-cell proliferation, possibly affecting IgG2a. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibits T-cell activation and proliferation, could lower IgG2a production. | ||||||
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | $76.00 $148.00 | 9 | |
Inhibits T-cell activation, potentially affecting IgG2a levels. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Antimalarial with immunomodulatory effects, may influence IgG2a production. | ||||||
FTY720 | 162359-56-0 | sc-202161 sc-202161A sc-202161B | 1 mg 5 mg 25 mg | $32.00 $75.00 $118.00 | 14 | |
Sphingosine 1-phosphate receptor modulator, potentially reducing IgG2a levels. | ||||||
Prednisone | 53-03-2 | sc-205816 sc-205816A sc-205816B | 1 g 5 g 25 g | $41.00 $133.00 $663.00 | 2 | |
Corticosteroid, suppresses immunity and could lower IgG2a production. | ||||||